(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Huntington’s Disease

The Department of Neurology at the University of Virginia Health System seeks adults with mild-to-moderate Huntington’s disease for a research study. The purpose of the study is to compare the effects of six months of daily dosing with an investigational drug vs. placebo on movement and symptoms of Huntington’s. This is a 12-month study requiring regular outpatient visits to check general health and effects of the study drug. Study-related drugs, visits and tests will be provided free of charge. Research site located in Charlottesville, Va.

More Information

Please see http://www.centerwatch.com/patient/studies/cat82.html.

—–

Asthma (Pediatric)

If your child has inadequately controlled allergic asthma, he or she may be eligible for a research study testing an investigational drug. Boys or girls ages 6 to 11 with moderate-to-severe persistent allergic asthma may be eligible. Qualified participants will receive study-related care, investigational drug and laboratory testing at no cost. You will also be compensated for your time. Research site located in Minneapolis, Minn.

More Information

Please see http://www.centerwatch.com/patient/studies/cat442.html.

—–

Irritable Bowel Syndrome (IBS)

If you have experienced constipation-related IBS during the past year, physicians are studying an investigational medication to see if it relieves symptoms. If you qualify, you will receive all study-related care [including physical examinations, laboratory services, and study medication]. Research site located in Laurel, Md.

More Information

Please see http://www.centerwatch.com/patient/studies/cat90.html.

—–

Copyright 2005 CenterWatch. All rights reserved.